This issue discusses palliative care and hematopoietic cell transplant, examines anticoagulation in patients with obesity, and more.
This issue explores COVID-19-associated coagulopathy, features frequently asked questions from oncologists, and more.
This supplement discusses the value of mutation testing for myeloid malignancies, reevaluates maintenance therapy in AML, and more.
This issue discusses AI's potential to improve patient care, debates using donors with clonal hematopoiesis for alloHCT, and more.
This issue examines immunization guidelines for patients with hematologic disorders, considers medical education amid the coronavirus pandemic, and more.
This issue looks at how cost-effective analyses are used to inform health-care decisions, explains the latest maintenance of certification requirements, and more.
This supplement takes a look at the future of chemoimmunotherapy for chronic lymphocytic leukemia, the latest FDA approvals for the treatment of lymphoid and plasma cell malignancies, and more.
This issue examines the high price of treating hemophilia, asks whether CAR T-cell therapies are worth the cost, and more.
This issue features highlights from the 2019 ASH Annual Meeting, reflections on physician wellness, and more.
This issue features a discussion about value-based care initiatives, coverage of late-breaking abstracts presented at the 2019 ASH Annual Meeting, and more.